Search

everythinglearnresearchcommunity

for

Search:↓

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

PCOS is a common and costly condition in North American women, causing various health issues like obesity, diabetes, and fertility problems.

The paper suggests that a decrease in estrogen receptor activity may cause sexual dysfunction syndromes and proposes hormonal treatments.

New tools show that in fish, NPY increases feeding and somatostatin decreases it.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

A rare ovarian cancer with a good outlook was found in a woman with unusual hair growth and abdominal symptoms.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

A Miniature Pinscher dog with hair loss and scaling was diagnosed with pattern alopecia and improved with melatonin treatment.

Cortisone may help hair regrow by altering the local environment, with regrowth starting 3-4 weeks after treatment, but its use is not widely recommended.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Both estrogens and androgens are important for health in both males and females.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

The testes produce important hormones like testosterone and others that play key roles in male body functions.

Nanotechnology improves Clomiphene citrate's effectiveness and reduces side effects for treating ovulatory disorders.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Certain gene variations are linked to a higher risk of severe acne, suggesting a genetic influence on the condition.